Package 0781-2368-01

Brand: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate

Generic: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 0781-2368-01
Digits Only 0781236801
Product NDC 0781-2368
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0781-2368-01)

Marketing

Marketing Status
Discontinued 2027-03-31
Brand dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Generic dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "11936c1c-41a8-481c-b12f-dcc5837968d2", "openfda": {"upc": ["0307812352014", "0307812335017", "0307812343012", "0307812368015", "0307812371015", "0307812329016"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_set_id": ["6f637e8d-7c2e-47fa-a43c-3250c51aed77"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0781-2368-01)", "package_ndc": "0781-2368-01", "marketing_end_date": "20270331", "marketing_start_date": "20090402"}], "brand_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate", "product_id": "0781-2368_11936c1c-41a8-481c-b12f-dcc5837968d2", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0781-2368", "dea_schedule": "CII", "generic_name": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "6.25 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "6.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "6.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "6.25 mg/1"}], "application_number": "NDA021303", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270331", "marketing_start_date": "20090402"}